Cargando…
Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAH(enu2) mouse model of PKU
Phenylketonuria (PKU) is a genetic disease characterized by the inability to convert dietary phenylalanine to tyrosine by phenylalanine hydroxylase. Given the importance of gut microbes in digestion, a genetically engineered microbe could potentially degrade some ingested phenylalanine from the diet...
Autores principales: | Durrer, Katherine E., Allen, Michael S., Hunt von Herbing, Ione |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435137/ https://www.ncbi.nlm.nih.gov/pubmed/28520731 http://dx.doi.org/10.1371/journal.pone.0176286 |
Ejemplares similares
-
New Strategies for the Treatment of Phenylketonuria (PKU)
por: Strisciuglio, Pietro, et al.
Publicado: (2014) -
The Adult Phenylketonuria (PKU) Gut Microbiome
por: Mancilla, Viviana J., et al.
Publicado: (2021) -
Phenylketonuria (PKU): A problem solved?
por: Brown, Christine S., et al.
Publicado: (2015) -
Creatine energy substrate increases bone density in the Pah(enu2) classical PKU mouse in the context of phenylalanine restriction
por: Dobrowolski, Steven F., et al.
Publicado: (2023) -
Living with phenylketonuria in adulthood: The PKU ATTITUDE study
por: Cazzorla, Chiara, et al.
Publicado: (2018)